Making a decision about ERT/HRT: Evidence to consider in initiating and continuing protective therapy

Postgraduate Medicine

Volumn 109, Issue 3, 2001, Pages 167-178

  Nerhood, Robert C ^a,b  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN; LIPID; MEDROXYPROGESTERONE ACETATE; PROGESTERONE;

ALZHEIMER DISEASE; ATHEROGENESIS; BLOOD VESSEL REACTIVITY; CARBOHYDRATE METABOLISM; CORONARY ARTERY DISEASE; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPID METABOLISM; MENOPAUSE; OSTEOPOROSIS; REVIEW; TREATMENT PLANNING;

EID: 0035099807     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2001.03.1770     Document Type: Review

References (20)

1. Compliance with long-term oral hormonal replacement therapy
2. Estrogen replacement therapy and risk of Alzheimer disease
3. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease. The Baltimore Longitudinal Study of Aging
4. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-control study
5. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
6. Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses' Health Study
7. Hormone therapy to prevent disease and prolong life in postmenopausal women
8. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women
9. Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women
10. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
11. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: Lack of an effect of added progesterone
12. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis
13. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
14. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys
15. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group
16. Long-term estrogen replacement therapy prevents bone loss and fractures
17. Menopausal estrogen therapy and hip fractures
18. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group
19. Maximizing the benefit of estrogen therapy for prevention of osteoporosis
20. Timing of postmenopausal estrogen for optimal bone mineral density: The Rancho Bernardo Study